KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Free Cash Flow (2016 - 2026)

Medtronic (MDT) has disclosed Free Cash Flow for 13 consecutive years, with $2.3 billion as the latest value for Q1 2026.

  • Quarterly Free Cash Flow rose 9.73% to $2.3 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.4 billion through Jan 2026, down 1.04% year-over-year, with the annual reading at $5.2 billion for FY2025, 0.29% changed from the prior year.
  • Free Cash Flow hit $2.3 billion in Q1 2026 for Medtronic, up from $457.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $2.4 billion in Q2 2024 to a low of $200.0 million in Q4 2023.
  • Historically, Free Cash Flow has averaged $1.3 billion across 5 years, with a median of $1.2 billion in 2023.
  • Biggest five-year swings in Free Cash Flow: crashed 66.61% in 2023 and later surged 177.0% in 2024.
  • Year by year, Free Cash Flow stood at $599.0 million in 2022, then plummeted by 66.61% to $200.0 million in 2023, then soared by 177.0% to $554.0 million in 2024, then dropped by 17.51% to $457.0 million in 2025, then skyrocketed by 403.28% to $2.3 billion in 2026.
  • Business Quant data shows Free Cash Flow for MDT at $2.3 billion in Q1 2026, $457.0 million in Q4 2025, and $584.0 million in Q3 2025.